In-Vitro Diagnostics (IVD) - Market Overview
In-vitro diagnostics is the backbone of healthcare, with over 1 billion tests performed annually in the UK alone. But as traditional IVD becomes increasingly commoditised, growth is shifting towards digital diagnostics. An M&A opportunity for established IVD players? 🚀
🚀 IVD: Traditional IVD is Commoditising. Where’s the Next Wave of Growth?
Traditional IVD is maturing, with lower growth rates and increasing price pressures. The next frontier? Digital diagnostics is scaling fast, delivering differentiated clinical value across the patient journey and unlocking new business models.
Why this matters:
✅ Aging Population & Chronic Diseases – Increasing demand for routine and early diagnostics.
✅ Regulatory Push – Governments fast-tracking reimbursement and compliance for high-quality diagnostics.
✅ Decentralised Testing – Expansion of at-home and mobile diagnostics for faster, more accessible results.
What this means:
🏥 For Healthcare Leaders - A chance to modernise diagnostic capabilities and drive efficiency
💰 For Investors & M&A - Acquire adjacent business models to optimise clinical pathways.
🔍 Are you exploring opportunities in IVD & digital diagnostics? Let’s talk!
👉 Open or download the PDF to read the full report.
Tech & Healthcare M&A Insights: Weekly market overviews and deal debriefs. Join the newsletter or follow our LinkedIn account.
